Clinical trial
AVE7688 in Patients With Mild to Moderate Blood Pressure
NCT00284128 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00284128 |
|---|---|
| Title | AVE7688 in Patients With Mild to Moderate Blood Pressure |
| Official title | Double-blind, Randomized, Parallel-group, Dose Ranging, Multicenter Study to Evaluate the Efficacy and Safety of 2.5, 10, 35 and 50 mg AVE 7688 Once Daily, Using 100 mg Losartan-potassium Once Daily as Calibrator, for 12 Months Treatment, in Patients With Mild to Moderate Hypertension |
| Acronym | RAVEL-1 |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | AVE7688, Losartan-potassium |
| Enrollment | 1,940 |
| Start date | Dec 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Jan 31, 2006 |
| Last update posted | May 18, 2016 |
| Countries | Argentina, Brazil, Canada, Chile, Germany, Greece, Hong Kong, Italy, Malaysia, Mexico, Netherlands, Poland and 9 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: